Return to Trial Database

HCRN-GI15-225

A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma With Preserved Liver Function. HCRN: GI15-225

Status

Study Completed

Cancer Type(s)

Liver and Bile Duct

Study Contact

Trial Locations

All sites in which the trial HCRN-GI15-225 being conducted in.

No data was found